Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis
NCT00310492
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
154
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL:
subcutaneous immunotherapy
Sponsor
ALK-Abelló A/S